Vijaya Diagnostic Centre growth over the years

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Compounded a year1 yr3 yr
Revenue+19.5%+21.0%
EBITDA+23.3%+22.8%
Net Income+20.3%+26.6%
EPS (adj.)+20.9%+26.9%
Total Assets+18.3%+20.9%
Total Equity+19.8%+20.5%
Free Cash Flow−31.9%+30.2%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

VIJAYA₹1,400.00

Vijaya Diagnostic Centre Ltd.

· Pharma & Health
₹ CrorePeersTHYROCAREMETROPOLISLALPATHLABRAINBOWPOLYMEDPFIZERONESOURCEKIMSMcap ₹14,406 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
3Y
CAGR
Revenue+19.5+21.0
EBITDA+23.3+22.8
Net Income+20.3+26.6
EPS (adj.)+20.9+26.9
Total Assets+18.3+20.9
Total Equity+19.8+20.5
Free Cash Flow-31.9+30.2
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.